LUPPI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 35.660
EU - Europa 15.272
AS - Asia 6.032
SA - Sud America 82
Continente sconosciuto - Info sul continente non disponibili 39
AF - Africa 30
OC - Oceania 25
Totale 57.140
Nazione #
US - Stati Uniti d'America 35.477
GB - Regno Unito 5.784
IT - Italia 3.372
SE - Svezia 1.965
CN - Cina 1.883
SG - Singapore 1.745
DE - Germania 1.258
HK - Hong Kong 1.166
UA - Ucraina 816
TR - Turchia 680
FI - Finlandia 630
BG - Bulgaria 383
FR - Francia 336
ID - Indonesia 140
IN - India 131
CA - Canada 118
IE - Irlanda 108
RU - Federazione Russa 102
BE - Belgio 83
NL - Olanda 75
CZ - Repubblica Ceca 74
VN - Vietnam 66
LT - Lituania 63
BZ - Belize 58
IR - Iran 53
BR - Brasile 47
ES - Italia 40
KR - Corea 39
EU - Europa 33
JP - Giappone 32
MY - Malesia 28
AU - Australia 25
RO - Romania 22
SI - Slovenia 21
CH - Svizzera 18
PL - Polonia 17
NO - Norvegia 14
AT - Austria 11
CL - Cile 11
DK - Danimarca 10
SK - Slovacchia (Repubblica Slovacca) 10
ZA - Sudafrica 10
GR - Grecia 9
PE - Perù 9
PK - Pakistan 9
PT - Portogallo 9
AR - Argentina 7
BD - Bangladesh 7
HR - Croazia 7
HU - Ungheria 7
IQ - Iraq 7
PH - Filippine 7
TW - Taiwan 7
IL - Israele 6
MK - Macedonia 6
NG - Nigeria 6
RS - Serbia 6
MX - Messico 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
SD - Sudan 4
CO - Colombia 3
CY - Cipro 3
EE - Estonia 3
EG - Egitto 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
SA - Arabia Saudita 3
A1 - Anonimo 2
BY - Bielorussia 2
ET - Etiopia 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
PY - Paraguay 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
GN - Guinea 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MN - Mongolia 1
MZ - Mozambico 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 57.140
Città #
Fairfield 5.246
Southend 4.804
Woodbridge 3.229
Ashburn 2.687
Chandler 2.610
Houston 2.581
Seattle 1.956
Santa Clara 1.819
Ann Arbor 1.769
Jacksonville 1.722
Wilmington 1.708
Cambridge 1.662
Dearborn 1.400
Singapore 1.369
Nyköping 1.251
Hong Kong 1.082
Modena 736
Beijing 508
San Diego 494
Princeton 431
New York 424
Izmir 420
Sofia 380
Helsinki 332
Eugene 319
Milan 234
London 199
Bologna 193
Fremont 169
Bremen 160
Des Moines 150
Jakarta 130
Rome 126
Shanghai 122
Redwood City 114
San Jose 114
Boardman 107
Dublin 96
Munich 94
Chicago 85
Philadelphia 83
Hefei 77
Dallas 71
Falls Church 71
Brussels 70
Norwalk 64
Kilburn 60
Belize City 58
Dong Ket 56
Toronto 56
Nanjing 54
Guangzhou 53
Las Vegas 53
Albuquerque 51
San Mateo 51
Kunming 50
Reggio Emilia 50
Verona 49
Parma 48
Brno 42
Chiswick 42
Ottawa 41
Saint Louis 40
Los Angeles 33
Hounslow 32
Frankfurt am Main 30
Leawood 29
Palermo 28
Washington 28
Nanchang 27
Tulare 27
Naples 26
Phoenix 26
Turin 25
Amsterdam 24
Jinan 24
San Francisco 23
Paris 22
Auburn Hills 21
Rimini 20
Columbus 19
Prescot 19
Wuhan 19
Bari 18
Madrid 18
San Giuliano Milanese 18
Castelnuovo Rangone 17
Lappeenranta 17
Acton 16
Atlanta 16
Dongguan 16
Grafing 16
Islington 16
Padova 16
Pavia 15
Perugia 15
Saint Petersburg 15
San Lazzaro di Savena 15
Zhengzhou 15
Bangalore 14
Totale 45.097
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 413
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 322
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 288
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 267
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 266
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 266
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 254
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 252
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 249
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 247
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 245
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 242
HHV-6A in syncytial giant-cell hepatitis 239
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 236
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 232
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 230
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 229
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 228
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 226
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 223
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 223
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 221
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 220
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 216
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 216
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 216
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 215
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 215
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 214
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 212
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 212
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 211
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 211
Mucorales-specific T cells in patients with hematologic malignancies 208
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 208
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 208
Acute appendicitis in adult neutropenic patients with hematologic malignancies 207
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 205
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 205
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 205
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 204
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 204
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 203
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 202
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 202
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 202
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 202
B cells and herpesviruses: a model of lymphoproliferation 201
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 200
Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain 199
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 197
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 197
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 197
Translational challenges of human herpesvirus 6 chromosomal integration. 196
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 196
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 196
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 196
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 196
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 195
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 194
Diagnosis of aspergillosis: Role of proteomics 194
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 194
Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report 192
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. 188
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 188
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 188
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 188
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 187
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 186
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 186
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 186
Parvoviruses in blood donors and transplant patients, Italy 185
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 184
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 184
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 183
How I treat HHV8/KSHV-related diseases in posttransplant patients. 182
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 182
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. 182
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 181
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 181
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 181
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 181
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 180
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 180
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 180
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 179
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 179
Breast Location for De Novo Extramedullary Myeloid Sarcoma 179
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction 179
Pain and emotional distress in leukemia patients at diagnosis. 178
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 177
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 177
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 176
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 176
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 176
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 176
Kaposi's sarcoma after liver transplantation 176
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 175
Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity. 175
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 175
Totale 20.657
Categoria #
all - tutte 269.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 269.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.315 0 0 0 0 1.199 1.692 2.303 1.635 1.004 431 565 486
2020/20219.293 695 407 661 1.058 1.113 892 645 1.091 385 1.096 634 616
2021/20227.626 429 921 761 423 209 387 457 379 811 560 1.263 1.026
2022/20237.922 981 833 575 700 1.066 1.089 168 789 949 127 338 307
2023/20245.850 204 312 371 497 1.142 482 643 885 124 177 336 677
2024/20254.489 665 248 295 1.276 2.005 0 0 0 0 0 0 0
Totale 57.992